Crossmark

Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives

Published Online: 2020-10-06

Published Print: 2021-03

Authors

Qu, Jingjing

Mei, Quanhui

Chen, Lijun https://orcid.org/0000-0001-9374-6466
Zhou, Jianying
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81670017)

National Natural Science Foundation of China (81900563)

National Natural Science Foundation of China (81802278)

Natural Science Foundation of Hunan Province (2019JJ50361)
License Information

Text and Data Mining valid from 2020-10-06

Version of Record valid from 2020-10-06
More Information

Article History

Received: 20 March 2020

Accepted: 20 September 2020

First Online: 6 October 2020

Compliance with ethical standards

:

: The author declares no competing financial interests.

: Not applicable.

: Not applicable.

Document is current